Lateral elbow extensor tendinopathy. Lateral epicondylitis
Conditions
Interventions
Intervention 1: First intervention group: Injection of platelet-rich plasma (PRP) produced by a kit manufactured by Celltech Biogen using the peppering method along with conventional treatments includ
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Pain or tenderness to touch over the lateral epicondylitis and the insertion site of the extensor tendons Pain with gripping a hand dynamometer The pain may be aggravated by stretching or contracting the wrist extensors. At least a score of 2 on the NRS scale from 0 to 10.
Exclusion criteria
Exclusion criteria: Have a history of surgery on the upper limb. Have had surgery related to the cervical spine. Have a history of elbow dislocation or elbow fracture or tendon rupture Have a history of whiplash injury within the past 6 weeks. Have a history of fibromyalgia Have a history of cervical canal stenosis History of chronic inflammatory disease such as: lupus - rheumatoid arthritis - psoriasis Failure to participate in physical therapy, acupuncture, or chiropractic in the past 3 months Having symptoms of nerve compression, such as weakness of upper limb muscles, decreased deep reflexes in the upper limb, and decreased sensation Central nervous system involvement, such as MS Neurological _ Psychiatric or cognitive disorders and pregnancy The presence of any contraindications for physical therapy, such as skin wounds, infections, and malignancies Absence of a bleeding disorder No use of NSAIDs, steroids, or aspirin within the previous week
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity. Timepoint: It is being evaluated 4 and 8 weeks after injection. Method of measurement: Pain intensity will be assessed using the Numerical Rating Scale (NRS), which ranges from 0 to 10, where 0 represents "no pain" and 10 represents "the worst possible pain.".;Grip strength. Timepoint: It is being evaluated 4 and 8 weeks after injection. Method of measurement: Grip strength will be measured using a hand-held dynamometer, which quantifies the maximum force exerted by the participant's grip.;The Pressure Pain Threshold. Timepoint: It is being evaluated 4 and 8 weeks after injection. Method of measurement: The Pressure Pain Threshold (PPT) will be measured using an algometer, a device that applies gradual pressure to a specific point on the body. The participant will report when the pressure becomes painful.;The Patient-Rated Tennis Elbow (PRTE) questionnaire. Timepoint: It is being evaluated 4 and 8 weeks after injection. Method of measurement: The Patient-Rated Tennis Elbow (PRTE) questionnaire evaluates the severity of symptoms and functional limitations caused by tennis elbow. It uses a Likert scale (0-10) for scoring, where 0 means "no pain" or "no difficulty," and 10 represents "worst possible pain" or "unable to perform the activity. Its subscales include 1. Pain Subscale : Measures pain intensity during rest and specific activities. 2. Function Subscale: Assesses limitations in daily activities and work tasks. 3. Impact on Quality of Life. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBahareh Golestani
Tehran University of Medical Sciences
Outcome results
None listed